Skip to content

Clinical trials

Phase 2/3 Obesity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 2/3 Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20052
20063
20083
20096
20105
20111
20121
20131
20141
20161
20173
20181
20193
20201
20212
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Active, not recruiting2
Recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University10
Mayo Clinic3
Joslin Diabetes Center2
University of Pittsburgh2
Cale Andrew Jacobs, PhD1
Cedars-Sinai Medical Center1
Crospon1
Durham VA Medical Center1
Glaser Pediatric Research Network1
Johns Hopkins University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity47
Overweight9
Binge-Eating Disorder6
Diabetes Mellitus, Type 26
Diabetes Mellitus3
Inflammation3
Weight Loss3
Cardiovascular Diseases2
Metabolic Syndrome2
Asthma1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.